Global Recombinant Protein Drugs Market Research Report 2017

Global Recombinant Protein Drugs Market Research Report 2017

1 Recombinant Protein Drugs Market Overview

1.1 Product Overview and Scope of Recombinant Protein Drugs

1.2 Recombinant Protein Drugs Segment by Type (Product Category)

1.2.1 Global Recombinant Protein Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)

1.2.2 Global Recombinant Protein Drugs Production Market Share by Type (Product Category) in 2016

1.2.3 Recombinant DNA

1.2.4 Recombinant RNA

1.3 Global Recombinant Protein Drugs Segment by Application

1.3.1 Recombinant Protein Drugs Consumption (Sales) Comparison by Application (2012-2022)

1.3.2 Pharmaceutical Industry

1.3.3 Other

1.4 Global Recombinant Protein Drugs Market by Region (2012-2022)

1.4.1 Global Recombinant Protein Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)

1.4.2 North America Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 China Status and Prospect (2012-2022)

1.4.5 Japan Status and Prospect (2012-2022)

1.4.6 Southeast Asia Status and Prospect (2012-2022)

1.4.7 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value) of Recombinant Protein Drugs (2012-2022)

1.5.1 Global Recombinant Protein Drugs Revenue Status and Outlook (2012-2022)

1.5.2 Global Recombinant Protein Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Recombinant Protein Drugs Market Competition by Manufacturers

2.1 Global Recombinant Protein Drugs Capacity, Production and Share by Manufacturers (2012-2017)

2.1.1 Global Recombinant Protein Drugs Capacity and Share by Manufacturers (2012-2017)

2.1.2 Global Recombinant Protein Drugs Production and Share by Manufacturers (2012-2017)

2.2 Global Recombinant Protein Drugs Revenue and Share by Manufacturers (2012-2017)

2.3 Global Recombinant Protein Drugs Average Price by Manufacturers (2012-2017)

2.4 Manufacturers Recombinant Protein Drugs Manufacturing Base Distribution, Sales Area and Product Type

2.5 Recombinant Protein Drugs Market Competitive Situation and Trends

2.5.1 Recombinant Protein Drugs Market Concentration Rate

2.5.2 Recombinant Protein Drugs Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Recombinant Protein Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)

3.1 Global Recombinant Protein Drugs Capacity and Market Share by Region (2012-2017)

3.2 Global Recombinant Protein Drugs Production and Market Share by Region (2012-2017)

3.3 Global Recombinant Protein Drugs Revenue (Value) and Market Share by Region (2012-2017)

3.4 Global Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.5 North America Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.6 Europe Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.7 China Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.8 Japan Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.9 Southeast Asia Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.10 India Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Recombinant Protein Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)

4.1 Global Recombinant Protein Drugs Consumption by Region (2012-2017)

4.2 North America Recombinant Protein Drugs Production, Consumption, Export, Import (2012-2017)

4.3 Europe Recombinant Protein Drugs Production, Consumption, Export, Import (2012-2017)

4.4 China Recombinant Protein Drugs Production, Consumption, Export, Import (2012-2017)

4.5 Japan Recombinant Protein Drugs Production, Consumption, Export, Import (2012-2017)

4.6 Southeast Asia Recombinant Protein Drugs Production, Consumption, Export, Import (2012-2017)

4.7 India Recombinant Protein Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Recombinant Protein Drugs Production, Revenue (Value), Price Trend by Type

5.1 Global Recombinant Protein Drugs Production and Market Share by Type (2012-2017)

5.2 Global Recombinant Protein Drugs Revenue and Market Share by Type (2012-2017)

5.3 Global Recombinant Protein Drugs Price by Type (2012-2017)

5.4 Global Recombinant Protein Drugs Production Growth by Type (2012-2017)

6 Global Recombinant Protein Drugs Market Analysis by Application

6.1 Global Recombinant Protein Drugs Consumption and Market Share by Application (2012-2017)

6.2 Global Recombinant Protein Drugs Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Recombinant Protein Drugs Manufacturers Profiles/Analysis

7.1 Novo Nordisk

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 Recombinant Protein Drugs Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 Novo Nordisk Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.1.4 Main Business/Business Overview

7.2 Amgen

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 Recombinant Protein Drugs Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 Amgen Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.2.4 Main Business/Business Overview

7.3 Sanofi

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 Recombinant Protein Drugs Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Sanofi Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.3.4 Main Business/Business Overview

7.4 Eli Lilly

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 Recombinant Protein Drugs Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Eli Lilly Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.4.4 Main Business/Business Overview

7.5 Merck Serono

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 Recombinant Protein Drugs Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Merck Serono Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.5.4 Main Business/Business Overview

7.6 Ortho Biotech

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 Recombinant Protein Drugs Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 Ortho Biotech Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.6.4 Main Business/Business Overview

7.7 Roche

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 Recombinant Protein Drugs Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 Roche Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.7.4 Main Business/Business Overview

7.8 Kyowa Hakko Kirin

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 Recombinant Protein Drugs Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.8.4 Main Business/Business Overview

7.9 Pharmingen

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 Recombinant Protein Drugs Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Pharmingen Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.9.4 Main Business/Business Overview

7.10 Abcam

7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.10.2 Recombinant Protein Drugs Product Category, Application and Specification

7.10.2.1 Product A

7.10.2.2 Product B

7.10.3 Abcam Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.10.4 Main Business/Business Overview

7.11 GenSci

7.12 SL PHARM

7.13 Dongbao Pharm

7.14 Ankebio

7.15 NCPC

7.16 Heng Rui

8 Recombinant Protein Drugs Manufacturing Cost Analysis

8.1 Recombinant Protein Drugs Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Recombinant Protein Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Recombinant Protein Drugs Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Recombinant Protein Drugs Market Forecast (2017-2022)

12.1 Global Recombinant Protein Drugs Capacity, Production, Revenue Forecast (2017-2022)

12.1.1 Global Recombinant Protein Drugs Capacity, Production and Growth Rate Forecast (2017-2022)

12.1.2 Global Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)

12.1.3 Global Recombinant Protein Drugs Price and Trend Forecast (2017-2022)

12.2 Global Recombinant Protein Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)

12.2.1 North America Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.2 Europe Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.3 China Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.4 Japan Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.5 Southeast Asia Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.6 India Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.3 Global Recombinant Protein Drugs Production, Revenue and Price Forecast by Type (2017-2022)

12.4 Global Recombinant Protein Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

Figure Picture of Recombinant Protein Drugs

Figure Global Recombinant Protein Drugs Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2012-2022)

Figure Global Recombinant Protein Drugs Production Market Share by Types (Product Category) in 2016

Figure Product Picture of Recombinant DNA

Table Major Manufacturers of Recombinant DNA

Figure Product Picture of Recombinant RNA

Table Major Manufacturers of Recombinant RNA

Figure Global Recombinant Protein Drugs Consumption (K Doses) by Applications (2012-2022)

Figure Global Recombinant Protein Drugs Consumption Market Share by Applications in 2016

Figure Pharmaceutical Industry Examples

Table Key Downstream Customer in Pharmaceutical Industry

Figure Other Examples

Table Key Downstream Customer in Other

Figure Global Recombinant Protein Drugs Market Size (Million USD), Comparison (K Doses) and CAGR (%) by Regions (2012-2022)

Figure North America Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure India Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global Recombinant Protein Drugs Revenue (Million USD) Status and Outlook (2012-2022)

Figure Global Recombinant Protein Drugs Capacity, Production (K Doses) Status and Outlook (2012-2022)

Figure Global Recombinant Protein Drugs Major Players Product Capacity (K Doses) (2012-2017)

Table Global Recombinant Protein Drugs Capacity (K Doses) of Key Manufacturers (2012-2017)

Table Global Recombinant Protein Drugs Capacity Market Share of Key Manufacturers (2012-2017)

Figure Global Recombinant Protein Drugs Capacity (K Doses) of Key Manufacturers in 2016

Figure Global Recombinant Protein Drugs Capacity (K Doses) of Key Manufacturers in 2017

Figure Global Recombinant Protein Drugs Major Players Product Production (K Doses) (2012-2017)

Table Global Recombinant Protein Drugs Production (K Doses) of Key Manufacturers (2012-2017)

Table Global Recombinant Protein Drugs Production Share by Manufacturers (2012-2017)

Figure 2016 Recombinant Protein Drugs Production Share by Manufacturers

Figure 2017 Recombinant Protein Drugs Production Share by Manufacturers

Figure Global Recombinant Protein Drugs Major Players Product Revenue (Million USD) (2012-2017)

Table Global Recombinant Protein Drugs Revenue (Million USD) by Manufacturers (2012-2017)

Table Global Recombinant Protein Drugs Revenue Share by Manufacturers (2012-2017)

Table 2016 Global Recombinant Protein Drugs Revenue Share by Manufacturers

Table 2017 Global Recombinant Protein Drugs Revenue Share by Manufacturers

Table Global Market Recombinant Protein Drugs Average Price (USD/Dose) of Key Manufacturers (2012-2017)

Figure Global Market Recombinant Protein Drugs Average Price (USD/Dose) of Key Manufacturers in 2016

Table Manufacturers Recombinant Protein Drugs Manufacturing Base Distribution and Sales Area

Table Manufacturers Recombinant Protein Drugs Product Category

Figure Recombinant Protein Drugs Market Share of Top 3 Manufacturers

Figure Recombinant Protein Drugs Market Share of Top 5 Manufacturers

Table Global Recombinant Protein Drugs Capacity (K Doses) by Region (2012-2017)

Figure Global Recombinant Protein Drugs Capacity Market Share by Region (2012-2017)

Figure Global Recombinant Protein Drugs Capacity Market Share by Region (2012-2017)

Figure 2016 Global Recombinant Protein Drugs Capacity Market Share by Region

Table Global Recombinant Protein Drugs Production by Region (2012-2017)

Figure Global Recombinant Protein Drugs Production (K Doses) by Region (2012-2017)

Figure Global Recombinant Protein Drugs Production Market Share by Region (2012-2017)

Figure 2016 Global Recombinant Protein Drugs Production Market Share by Region

Table Global Recombinant Protein Drugs Revenue (Million USD) by Region (2012-2017)

Table Global Recombinant Protein Drugs Revenue Market Share by Region (2012-2017)

Figure Global Recombinant Protein Drugs Revenue Market Share by Region (2012-2017)

Table 2016 Global Recombinant Protein Drugs Revenue Market Share by Region

Figure Global Recombinant Protein Drugs Capacity, Production (K Doses) and Growth Rate (2012-2017)

Table Global Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Table North America Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Table Europe Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Table China Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Table Japan Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Table Southeast Asia Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Table India Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Table Global Recombinant Protein Drugs Consumption (K Doses) Market by Region (2012-2017)

Table Global Recombinant Protein Drugs Consumption Market Share by Region (2012-2017)

Figure Global Recombinant Protein Drugs Consumption Market Share by Region (2012-2017)

Figure 2016 Global Recombinant Protein Drugs Consumption (K Doses) Market Share by Region

Table North America Recombinant Protein Drugs Production, Consumption, Import & Export (K Doses) (2012-2017)

Table Europe Recombinant Protein Drugs Production, Consumption, Import & Export (K Doses) (2012-2017)

Table China Recombinant Protein Drugs Production, Consumption, Import & Export (K Doses) (2012-2017)

Table Japan Recombinant Protein Drugs Production, Consumption, Import & Export (K Doses) (2012-2017)

Table Southeast Asia Recombinant Protein Drugs Production, Consumption, Import & Export (K Doses) (2012-2017)

Table India Recombinant Protein Drugs Production, Consumption, Import & Export (K Doses) (2012-2017)

Table Global Recombinant Protein Drugs Production (K Doses) by Type (2012-2017)

Table Global Recombinant Protein Drugs Production Share by Type (2012-2017)

Figure Production Market Share of Recombinant Protein Drugs by Type (2012-2017)

Figure 2016 Production Market Share of Recombinant Protein Drugs by Type

Table Global Recombinant Protein Drugs Revenue (Million USD) by Type (2012-2017)

Table Global Recombinant Protein Drugs Revenue Share by Type (2012-2017)

Figure Production Revenue Share of Recombinant Protein Drugs by Type (2012-2017)

Figure 2016 Revenue Market Share of Recombinant Protein Drugs by Type

Table Global Recombinant Protein Drugs Price (USD/Dose) by Type (2012-2017)

Figure Global Recombinant Protein Drugs Production Growth by Type (2012-2017)

Table Global Recombinant Protein Drugs Consumption (K Doses) by Application (2012-2017)

Table Global Recombinant Protein Drugs Consumption Market Share by Application (2012-2017)

Figure Global Recombinant Protein Drugs Consumption Market Share by Applications (2012-2017)

Figure Global Recombinant Protein Drugs Consumption Market Share by Application in 2016

Table Global Recombinant Protein Drugs Consumption Growth Rate by Application (2012-2017)

Figure Global Recombinant Protein Drugs Consumption Growth Rate by Application (2012-2017)

Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novo Nordisk Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Novo Nordisk Recombinant Protein Drugs Production Growth Rate (2012-2017)

Figure Novo Nordisk Recombinant Protein Drugs Production Market Share (2012-2017)

Figure Novo Nordisk Recombinant Protein Drugs Revenue Market Share (2012-2017)

Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Amgen Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Amgen Recombinant Protein Drugs Production Growth Rate (2012-2017)

Figure Amgen Recombinant Protein Drugs Production Market Share (2012-2017)

Figure Amgen Recombinant Protein Drugs Revenue Market Share (2012-2017)

Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sanofi Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Sanofi Recombinant Protein Drugs Production Growth Rate (2012-2017)

Figure Sanofi Recombinant Protein Drugs Production Market Share (2012-2017)

Figure Sanofi Recombinant Protein Drugs Revenue Market Share (2012-2017)

Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Eli Lilly Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Eli Lilly Recombinant Protein Drugs Production Growth Rate (2012-2017)

Figure Eli Lilly Recombinant Protein Drugs Production Market Share (2012-2017)

Figure Eli Lilly Recombinant Protein Drugs Revenue Market Share (2012-2017)

Table Merck Serono Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck Serono Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Merck Serono Recombinant Protein Drugs Production Growth Rate (2012-2017)

Figure Merck Serono Recombinant Protein Drugs Production Market Share (2012-2017)

Figure Merck Serono Recombinant Protein Drugs Revenue Market Share (2012-2017)

Table Ortho Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Ortho Biotech Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Ortho Biotech Recombinant Protein Drugs Production Growth Rate (2012-2017)

Figure Ortho Biotech Recombinant Protein Drugs Production Market Share (2012-2017)

Figure Ortho Biotech Recombinant Protein Drugs Revenue Market Share (2012-2017)

Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Roche Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Roche Recombinant Protein Drugs Production Growth Rate (2012-2017)

Figure Roche Recombinant Protein Drugs Production Market Share (2012-2017)

Figure Roche Recombinant Protein Drugs Revenue Market Share (2012-2017)

Table Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Kyowa Hakko Kirin Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Kyowa Hakko Kirin Recombinant Protein Drugs Production Growth Rate (2012-2017)

Figure Kyowa Hakko Kirin Recombinant Protein Drugs Production Market Share (2012-2017)

Figure Kyowa Hakko Kirin Recombinant Protein Drugs Revenue Market Share (2012-2017)

Table Pharmingen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pharmingen Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Pharmingen Recombinant Protein Drugs Production Growth Rate (2012-2017)

Figure Pharmingen Recombinant Protein Drugs Production Market Share (2012-2017)

Figure Pharmingen Recombinant Protein Drugs Revenue Market Share (2012-2017)

Table Abcam Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Abcam Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)

Figure Abcam Recombinant Protein Drugs Production Growth Rate (2012-2017)

Figure Abcam Recombinant Protein Drugs Production Market Share (2012-2017)

Figure Abcam Recombinant Protein Drugs Revenue Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Recombinant Protein Drugs

Figure Manufacturing Process Analysis of Recombinant Protein Drugs

Figure Recombinant Protein Drugs Industrial Chain Analysis

Table Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2016

Table Major Buyers of Recombinant Protein Drugs

Table Distributors/Traders List

Figure Global Recombinant Protein Drugs Capacity, Production (K Doses) and Growth Rate Forecast (2017-2022)

Figure Global Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Recombinant Protein Drugs Price (Million USD) and Trend Forecast (2017-2022)

Table Global Recombinant Protein Drugs Production (K Doses) Forecast by Region (2017-2022)

Figure Global Recombinant Protein Drugs Production Market Share Forecast by Region (2017-2022)

Table Global Recombinant Protein Drugs Consumption (K Doses) Forecast by Region (2017-2022)

Figure Global Recombinant Protein Drugs Consumption Market Share Forecast by Region (2017-2022)

Figure North America Recombinant Protein Drugs Production (K Doses) and Growth Rate Forecast (2017-2022)

Figure North America Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table North America Recombinant Protein Drugs Production, Consumption, Export and Import (K Doses) Forecast (2017-2022)

Figure Europe Recombinant Protein Drugs Production (K Doses) and Growth Rate Forecast (2017-2022)

Figure Europe Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Europe Recombinant Protein Drugs Production, Consumption, Export and Import (K Doses) Forecast (2017-2022)

Figure China Recombinant Protein Drugs Production (K Doses) and Growth Rate Forecast (2017-2022)

Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table China Recombinant Protein Drugs Production, Consumption, Export and Import (K Doses) Forecast (2017-2022)

Figure Japan Recombinant Protein Drugs Production (K Doses) and Growth Rate Forecast (2017-2022)

Figure Japan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Japan Recombinant Protein Drugs Production, Consumption, Export and Import (K Doses) Forecast (2017-2022)

Figure Southeast Asia Recombinant Protein Drugs Production (K Doses) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Southeast Asia Recombinant Protein Drugs Production, Consumption, Export and Import (K Doses) Forecast (2017-2022)

Figure India Recombinant Protein Drugs Production (K Doses) and Growth Rate Forecast (2017-2022)

Figure India Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table India Recombinant Protein Drugs Production, Consumption, Export and Import (K Doses) Forecast (2017-2022)

Table Global Recombinant Protein Drugs Production (K Doses) Forecast by Type (2017-2022)

Figure Global Recombinant Protein Drugs Production (K Doses) Forecast by Type (2017-2022)

Table Global Recombinant Protein Drugs Revenue (Million USD) Forecast by Type (2017-2022)

Figure Global Recombinant Protein Drugs Revenue Market Share Forecast by Type (2017-2022)

Table Global Recombinant Protein Drugs Price Forecast by Type (2017-2022)

Table Global Recombinant Protein Drugs Consumption (K Doses) Forecast by Application (2017-2022)

Figure Global Recombinant Protein Drugs Consumption (K Doses) Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Source